124 related articles for article (PubMed ID: 1591693)
21. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
22. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
Uchida A; Micksche M; Hoshino T
Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
[TBL] [Abstract][Full Text] [Related]
23. In vitro augmentation of natural killing activity by OK-432.
Uchida A; Micksche M
Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
[TBL] [Abstract][Full Text] [Related]
24. Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro.
Sakano S; Shimabukuro T; Ohmoto Y; Naito K
Urol Res; 1997; 25(4):239-45. PubMed ID: 9286031
[TBL] [Abstract][Full Text] [Related]
25. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70.
Wei Y; Zhao X; Kariya Y; Fukata H; Teshigawara K; Uchida A
Cancer Res; 1996 Mar; 56(5):1104-10. PubMed ID: 8640768
[TBL] [Abstract][Full Text] [Related]
26. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells.
Nio Y; Zighelboim J; Berek J; Bonavida B
Cancer; 1989 Jul; 64(2):434-41. PubMed ID: 2736490
[TBL] [Abstract][Full Text] [Related]
29. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
30. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
31. Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma.
Kagawa S; Ogura K; Kurokawa K; Uyama K
J Urol; 1979 Oct; 122(4):467-70. PubMed ID: 480487
[TBL] [Abstract][Full Text] [Related]
32. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
[TBL] [Abstract][Full Text] [Related]
33. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.
Satoh K; Kan N; Okino T; Mise K; Yamasaki S; Harada T; Hori T; Ohgaki K; Tobe T
Biotherapy; 1993; 6(1):41-9. PubMed ID: 8507544
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
[TBL] [Abstract][Full Text] [Related]
35. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
36. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
37. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
Wu XX; Zeng Y; Jin XH; Kakehi Y
Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
[TBL] [Abstract][Full Text] [Related]
38. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
39. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro.
Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT
Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153
[TBL] [Abstract][Full Text] [Related]
40. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
Uchida A; Micksche M
Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]